Skip to Main Content

Paper Details

ELF5 is a potential respiratory epithelial cell-specific risk gene for severe COVID-19.
Nat Commun
8
2022
ACE2, COVID, COVID-, COVID-19, COVID-19 infection, ELF5, RAB2A, SARS, SARS-CoV, SARS-CoV-2, TMPRSS2, epithelial cells, human, plasma ELF5, respiratory epithelial cell, respiratory epithelial cell-specific risk gene, secretory and alveolar type 2 cells, single, transcription factor ELF5
Author NameAffiliation
Eleanor WheelerUniversity of Cambridge
Saskia TrumpCenter for Digital Health, Berlin Institute of Health (BIH) at Charite - Universitatsmedizin Berlin
Saskia TrumpCenter for Digital Health, Berlin Institute of Health (BIH) at Charite - Universitatsmedizin Berlin
Frank L HeppnerCharite - Universitatsmedizin Berlin, corporate member of Freie Universitat Berlin und Humboldt-Universitat zu Berlin
Frank L HeppnerGerman Center for Neurodegenerative Diseases (DZNE) Berlin
Frank L Heppner
Roland EilsCenter for Digital Health, Berlin Institute of Health (BIH) at Charite - Universitatsmedizin Berlin
Roland EilsGerman Center for Lung Research (DZL)
Roland EilsHeidelberg University Hospital and BioQuant
Roland EilsCenter for Digital Health, Berlin Institute of Health (BIH) at Charite - Universitatsmedizin Berlin
Roland EilsHeidelberg University Hospital and BioQuant
Roland EilsGerman Center for Lung Research (DZL)
John Brent RichardsMcGill University
John Brent RichardsLady Davis Institute, Jewish General Hospital
John Brent RichardsMcGill University
John Brent RichardsKing's College London
John Brent RichardsMcGill University
John Brent RichardsLady Davis Institute, Jewish General Hospital
John Brent RichardsMcGill University
John Brent RichardsKing's College London
Nicholas J WarehamUniversity of Cambridge
Claudia LangenbergBerlin Institute of Health (BIH) at Charite - Universitatsmedizin Berlin
Claudia LangenbergUniversity of Cambridge
  • 1 - 23

Datasets

Release 1.2